investment

News

AstraZeneca plans new US R&D hub as revenues rocket

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology

News

group of chemical scientists working at the laboratory.

Canary Wharf makes play to become UK life sciences hub

The organisation behind the iconic Canary Wharf development has said it plans to build one of the largest commercial laboratory facilities in Europe as part of a drive to make the east Lond

News

Jazz breaks ground on $100m UK plant for cannabinoid drugs

Jazz Pharma has started construction of a manufacturing facility in the UK that will be used to manufacture cannabinoid drugs from its recently

News

NHS said to be central to Moderna interest in UK facility

Moderna is reportedly in late-stage negotiations with the UK government that could result in a new research and manufacturing facility being set up in the biotech 'golden triangle' between

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Otsuka dips its toe in psychedelic waters, backing Mindset P...

Despite the growing interest in developing medicines based on psychedelic compounds, big pharma has seemed a bit wary of getting involved, leaving the task to small start-ups.

Views & Analysis

When biotech meets reality TV - Starton Therapeutics faces t...

Starton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that delivers medicine through the skin.

AstraZeneca plans new US R&D hub as revenues rocket

Canary Wharf makes play to become UK life sciences hub

Jazz breaks ground on $100m UK plant for cannabinoid drugs

NHS said to be central to Moderna interest in UK facility

Otsuka dips its toe in psychedelic waters, backing Mindset P...

When biotech meets reality TV - Starton Therapeutics faces t...

Nuvalent buy delivers new cancer approval for GSK

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks